Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q3 2025 (September 30)7holders
1new positions
1sold out
$25.29avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were FMR LLC ($18.3M), Wealth Enhancement Advisory Services, LLC ($17.5M) and Jane Street Group, LLC ($1.2M).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $22K |
| Exits | 1 | $14K |
All 13F filers, Q2 2025 → Q3 2025: 27,209 shares bought and 6,020 shares sold, net +21,189 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| FMR LLC | 0.00% | Reduce -0.0% | 732,995 | $18.3M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Reduce -0.8% | 683,362 | $17.5M |
| Jane Street Group, LLC | 0.00% | Add +126.8% | 46,784 | $1.2M |
| Glass Jacobson Investment Advisors llc | 0.01% | New | 875 | $22K |
| UBS Group AG | 0.00% | Add +30.3% | 761 | $19K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.